Q: Endo is still making money but the share price has dropped about 80 percent and they have a high debt load. How aggressively will they persue selling assets to lower the debt load and are repayments in the near future a concern? I do not own Endo but do own Knight and I was a shareholder in Palladin. THANKYOU
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hello 5i,
I don't have much healthcare exposure right now but I'm thinking about getting back in. I noticed the resent many reasonably priced options in Canada - CRH and GUD seem like the go to names but each have massive P/E ratios.
As a result, I was thinking about buying a US retail pharma stock like CVS or just buying the XLV instead. I like CVS as it is kinda like "owning the race track instead of the the race car". Am I hitting the mark with this analogy or am I missing something? Some Bio tech names appear quite cheap due to pricing/political risk etc. But I also would never know which one to buy. Do you see any issues with the CVS in general? Would you recommend just buying the XLV instead? Thanks
I don't have much healthcare exposure right now but I'm thinking about getting back in. I noticed the resent many reasonably priced options in Canada - CRH and GUD seem like the go to names but each have massive P/E ratios.
As a result, I was thinking about buying a US retail pharma stock like CVS or just buying the XLV instead. I like CVS as it is kinda like "owning the race track instead of the the race car". Am I hitting the mark with this analogy or am I missing something? Some Bio tech names appear quite cheap due to pricing/political risk etc. But I also would never know which one to buy. Do you see any issues with the CVS in general? Would you recommend just buying the XLV instead? Thanks
Q: Hi,
Any idea when GUD will be announcing earnings?
Thanks!
Any idea when GUD will be announcing earnings?
Thanks!
Q: I would appreciate if you can provide your thoughts about Neptune. What are their strengths and weaknesses. would you consider the stock a buy at this level.
Q: Can you provide insight on CRH Medical? Cantor Fitzgerald has a $7.00 target price. Looks interesting.
Thank you
Marty
Thank you
Marty
Q: I have been thinking about adding medical services to my portfolio.
There are several, in your opinion which one would you be better for the long term and dividend.
John
There are several, in your opinion which one would you be better for the long term and dividend.
John
Q: Can we get your opinion on TH with regards to:
- financial results announced Feb.8/17
- results of recent tests of their product
- is their a chance this company could become a portfolio changer, I mean should I average up and take this to a 3% position from 1.5%
Thanks for your great service as I would likely not heard of a company like TH without being a member
- financial results announced Feb.8/17
- results of recent tests of their product
- is their a chance this company could become a portfolio changer, I mean should I average up and take this to a 3% position from 1.5%
Thanks for your great service as I would likely not heard of a company like TH without being a member
Q: Prometic: you are probably up to speed on this one by now but do not see anything on the Q&A section. But California Capital Equity picked up 44M shares ... warrants at 0.47 cents. Dumb questions looking at the drop in price today (-7%). I am assuming this is not looked upon favourably?
Q: Regarding PLI's drop, if there is no apparent reason, does it indicate that the stock is being manipulated in some way? Does a halt like this with no apparent reason for the drop concern 5i as it is one of your "holdings"?
Q: In replying to Jim regarding PLI being halted you mentioned that the company had issued a press release indicating there were no material events to account for the drop. The last press release listed on PLI's website is dated Feb 6. Neither the website of TSX nor IIROC mention PLI's press release. Where did you see it? Is it available to the general public? If so can you tell me where?
Thanks
Thanks
Q: I know US stocks aren't your thing, but could you give me an opinion on Molina Healthcare. It looks very interesting to me after it's 17% drop yesterday.
Q: Trading was halted. Know of any reason? Jim
Q: Hi Team, apples to oranges but I bought GILD a while back for growth. What would you consider if deciding to switch to CRH Medical. Size, geography, I know. But for a five year growth play does this make any sense from a risk return perspective? Thank you, Michael
Q: Greetings 5i,
What is going on with VRX the past couple days? Seems to be moving up but I haven't found any news. What is your take on the company?
Cheers!
What is going on with VRX the past couple days? Seems to be moving up but I haven't found any news. What is your take on the company?
Cheers!
Q: Mr. Hodson, GUD is on a loosing slide currently ? Any problem ?
Q: Endo (ENDP) is up 7% this morning on heavy volume. Can you speculate why? They are reporting and giving an update on Feb.28. If they categorically state they are not selling Paladin, would Knight shares get hammered?
Thanks.
Thanks.
Q: any ides what is pushing PLI up today?
Q: What is your outlook for US biotech sector for the next 2 years? There are concerns about drug price negotiation by the Trump
administration. Do you think this is already priced in? I plan to take a position using IBB.
administration. Do you think this is already priced in? I plan to take a position using IBB.
Q: Bioamber got hit pretty hard after its recent financing. Am I right to think this was sold off due to the dilution nature of the over subscription. That said what is your thoughts on the company going forward.
Q: Can you please comment or provide any opinion on ATE phase2 trials for their ATB-346 drug? my understanding is that results of liver tests in test patients have provided mixed results from the trials. Also please provide forecast for share price going forward based on potential drug trial success? I know they have been obtaining private funds and i believe GUD has 10 or 20% stake in ATE. thanks